Thomas O Daniel's Net Worth
$28.2 Million
Who is Thomas O Daniel?
Thomas O Daniel has an estimated net worth of $28.2 Million. This is based on reported shares across multiple companies, which include Gossamer Bio, Inc., Magenta Therapeutics, Inc., ZAFGEN, INC., Epizyme, Inc., Juno Therapeutics, Inc., and CELGENE CORP /DE/.
SEC CIK
Thomas O Daniel's CIK is 0001538894
Past Insider Trading and Trends
2015 was Thomas O Daniel's most active year for acquiring shares with 22 total transactions. Thomas O Daniel's most active month to acquire stocks was the month of May. 2015 was Thomas O Daniel's most active year for disposing of shares, totalling 21 transactions. Thomas O Daniel's most active month to dispose stocks was the month of July. 2013 saw Thomas O Daniel paying a total of $4,676,423.51 for 150,524 shares, this is the most they've acquired in one year. In 2014 Thomas O Daniel cashed out on 190,852 shares for a total of $12,438,866.19, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gossamer Bio, Inc. (GOSS) Snapshot price: $0.9657
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 38.09K |
—
|
—
| 38.09K |
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Magenta Therapeutics, Inc. (DNTH) Snapshot price: $26.62
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +31.69% | 24.53K |
—
|
—
| 101.93K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Larimar Therapeutics, Inc. (LRMR) Snapshot price: $8.05
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +80.70% | 8.69K |
$5.18 | $44,998.66 | 19.45K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
∞
| 10.77K |
$4.18 | $44,997.70 | 10.77K |
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Juno Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||